Procter & Gamble Health Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

PGHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.5%1-day move

₹4789.00

prior close

₹4811.00

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.1+0.1+0.3+0.2+0.5+0.6+0.2+3.4+3.7+4.6+6.9+11.7+29.0+32.5

Up moveDown movePending

AI summary

Procter & Gamble Health Limited has submitted a regulatory compliance certificate confirming that details of securities dematerialised or rematerialised during Q4 FY2026 (January-March 2026) were furnished to NSE and BSE within the prescribed time. The company received confirmation from its Registrar and Transfer Agent, Kfin Technologies Limited, which serves as the official intermediary for both NSDL and CDSL. This filing is a mandatory quarterly requirement under SEBI regulations to ensure proper tracking of share dematerialisation activity. The company secretary Zeal Rupani signed the certificate dated April 6, 2026.

Likely market impact

This is a routine regulatory compliance filing and has no direct impact on the company's financial performance or stock price. It simply confirms the company followed proper procedures for share dematerialisation reporting.